A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer.
about
Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer.Neoadjuvant treatment for resectable pancreatic adenocarcinoma.Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.
P2860
A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase I study of neoadjuvant ...... resectable pancreatic cancer.
@en
A phase I study of neoadjuvant ...... resectable pancreatic cancer.
@nl
type
label
A phase I study of neoadjuvant ...... resectable pancreatic cancer.
@en
A phase I study of neoadjuvant ...... resectable pancreatic cancer.
@nl
prefLabel
A phase I study of neoadjuvant ...... resectable pancreatic cancer.
@en
A phase I study of neoadjuvant ...... resectable pancreatic cancer.
@nl
P2093
P2860
P356
P1476
A phase I study of neoadjuvant ...... resectable pancreatic cancer.
@en
P2093
Hidehiro Tajima
Hideto Fujita
Hirohisa Kitagawa
Hironori Hayashi
Hiroshi Itoh
Hiroyuki Furukawa
Hiroyuki Takamura
Hisatoshi Nakagawara
Isamu Makino
Itasu Ninomiya
P2860
P304
P356
10.3892/MCO.2013.133
P577
2013-05-27T00:00:00Z